Pramodini Medicare IPO

About Pramodini Medicare IPO

The Pramodini Medicare IPO, an SME IPO, opens on Wednesday, August 12, 2026 and closes on Friday, August 14, 2026. The allotment of shares will take place on Monday, August 17, 2026. The credit of shares to the demat account will take place on Tuesday, August 18, 2026. The initiation of refunds will take place on Tuesday, August 18, 2026. The listing of shares will take place on Wednesday, August 19, 2026.

The equity shares of the company are proposed to be listed on the NSE SME platform. The offer consists of both a fresh issue and an offer for sale component. The fresh issue will include 53,50,800 shares aggregating up to ₹63 crore. The offer for sale portion includes 5,00,400 shares aggregating up to ₹6 crore. The total number of shares and aggregate amount are 58,51,200 shares aggregating up to ₹69 crore.

Pramodini Medicare IPO's price band is set at ₹110 to ₹118 per share. The lot size for an application is 1,200 shares, with a minimum application of 2 lots. The minimum amount of investment required by a retail investor is ₹2,83,200 (2,400 shares) based on the upper price.

Pramodini Medicare is a diagnostic service provider operating a range of technology-enabled radiology, clinical laboratory, and nuclear medicine services across tier I, tier II, and tier III cities in India.

Objectives of Pramodini Medicare IPO

The company proposes to utilise the net proceeds from the fresh issue towards the following objects:

• Funding of capital expenditure for purchase of medical equipments towards existing and proposed diagnostic centres.
  
• General corporate purposes.
  

Industry Outlook

Diagnostics sits at the core of India's healthcare delivery system. The Indian healthcare sector, valued at ₹31,87,668 crore (US$ 372 billion) in 2023, is projected to reach ₹54,67,022 crore (US$ 638 billion) by 2025, growing at a 17.5–22.5% CAGR driven by innovation across hospitals, pharmaceuticals, and diagnostics. Demand is broadening well beyond the metros. Healthcare demand in tier II and tier III cities is projected to grow at a 16–18% CAGR over the coming years, higher than the 12–14% CAGR expected in metros.

Hospitals anchor much of this demand. India's hospital market is expected to be valued at US$ 135.3 billion in FY2026 and is projected to reach US$ 202.5 billion by 2030, growing at a CAGR of around 10.6%.

About Pramodini Medicare Limited

Pramodini Medicare is a diagnostic service provider in India. It offers radiology, clinical laboratory, and nuclear medicine services to public hospitals, private hospitals, certain public sector undertakings of the Government of India, and medical colleges across tier I, tier II, and tier III cities. Its radiology offering spans MRI, CT scan, X-ray, ultrasound with colour doppler, mammography, Dexa scan, and intervention radiology, while its nuclear medicine offering includes PET-CT, SPECT, and nuclear therapy. Teleradiology runs on a 24×7 basis from its registered office in Vijayawada.

The Company operates through four models: Public Private Partnership, Private Private Partnership, Strategic Partnership with PSUs of the Government of India, and Private standalone centres. It has 16 centres across 14 cities in seven states — Uttar Pradesh, Andhra Pradesh, Karnataka, West Bengal, Haryana/NCR Delhi, Madhya Pradesh, and Kerala

Strengths of Pramodini Medicare

• Establishing a strategic presence across various states in India.
  
• Strengthening our network through diversified models.
  
• Strong technical capabilities supported by robust IT infrastructure.
  
• Dedicated management team with significant industry experience.
  
• Strong track record of revenue growth and financial performance.
  
• Diverse customer and patient base.

Risks of Pramodini Medicare

• A significant portion of revenue comes from MOUs with government authorities under Public Private Partnership arrangements, so non-renewal, modification, or delayed government payments would directly hurt cash flows and results.
  
• A substantial share of revenue is derived from Andhra Pradesh, so any loss of business in that state would materially affect the Company's income.
  
• The business depends on a number of key customers cum patients, and the loss of any of them would remove a meaningful portion of revenue.
  

Anchor Investor Bidding Date

Tuesday, August 11, 2026

IPO Registrar and Book Running Lead Managers

IPO Registrar
Purva Sharegistry (India) Private Limited
E-mail: newissue@purvashare.com
Telephone: 022 - 49614132

Book Running Lead Manager
Smart Horizon Capital Advisors Private Limited

Pramodini Medicare Contact Details
D. No: - 29-4-54K, CSI Complex, Prakasam, Road, Suryaraopet,
Vijayawada, Andhra Pradesh, India – 520002.
Email: investors@pramodinidiagnostics.com
Telephone: +91 9985782727

Pramodini Medicare Business Model

The company earns its revenue through fees for diagnostic and related healthcare services delivered across its network of hospital-partnered and standalone centres. Its four operating models are Public Private Partnership with government and teaching hospitals, Private Private Partnership with private hospitals, Strategic Partnership with PSUs of the Government of India, and private standalone centres.

Under the partnership models, the Company sets up and manages in-hospital diagnostic centres on the partner's premises under MOUs, providing onsite radiology, clinical laboratory, and nuclear medicine testing. It serves B2G, B2B, and B2C segments, which contributed 61.46%, 20.82%, and 17.72% of revenue from operations in FY26, respectively, and it also offers customised health and wellness packages to patients.

Pramodini Medicare Growth Trajectory

Pramodini Medicare Limited's Total Income for FY26 was ₹63.38 crore, whereas in FY25 and FY24 it was ₹38.55 crore and ₹35.79 crore, respectively.

The Profit After Tax for FY26 was ₹17.38 crore, whereas in FY25 and FY24 it was ₹11.03 crore and ₹6.93 crore, respectively.

Their EBITDA for FY26 was ₹31.99 crore, whereas in FY25 and FY24 it was ₹21.27 crore and ₹16.10 crore, respectively.

Pramodini Medicare Market Position

The Company operates 16 diagnostic centres across 14 cities in seven states, with a processing unit cum laboratory in Vijayawada and 24×7 teleradiology from its registered office. Its centres run under Public Private Partnership, Private Private Partnership, Strategic Partnership with PSUs, and private standalone models, embedding it within partner hospital premises. Its diverse customer base spans B2G, B2B, and B2C segments across radiology, clinical laboratory, and nuclear medicine services.

As of 31 March 2026, the company's Total Income, Profit After Tax, and EBITDA were ₹63.38 crore, ₹17.38 crore, and ₹31.99 crore, respectively.

How to apply for Pramodini Medicare IPO?

• Step 1: Log in to your Kotak Neo Demat account to access IPO investments. Next, select the current IPO section.
• Step 2: Specify IPO details. Enter the number of lots and the price you wish to apply for.
• Step 3: Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.
• Step 4: Mandate Notification. Your UPI app will receive a mandate notification to block funds.
• Step 5: Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.